- Home
- TLSA vs FORR Comparison
TLSA vs FORR Comparison
Compare TLSA & FORR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TLSA | FORR |
|---|---|---|
| Founded | 2013 | 1983 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Diversified Commercial Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 192.1M | 154.9M |
| IPO Year | 2000 | 1996 |
Fundamental Metrics
Financial Performance| Metric | TLSA | FORR |
|---|---|---|
| Price | $1.37 | $7.27 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 342.9K | 79.8K |
| Earning Date | 05-06-2025 | 02-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $403,871,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.63 | $6.60 |
| 52 Week High | $2.60 | $15.26 |
Technical Indicators
Market Signals| Indicator | TLSA | FORR |
|---|---|---|
| Relative Strength Index (RSI) | 35.75 | 38.03 |
| Support Level | $1.25 | $6.90 |
| Resistance Level | $1.77 | $7.36 |
| Average True Range (ATR) | 0.11 | 0.30 |
| MACD | -0.03 | -0.12 |
| Stochastic Oscillator | 5.77 | 26.49 |
Price Performance
Historical ComparisonAbout TLSA Tiziana Life Sciences Ltd.
Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in developing transformative therapies for neurodegenerative and neuroinflammatory diseases. Its clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, ALS. Alzheimer's, Crohn's Disease, and KRAS+ NSCLC. Tiziana is led by a team of qualified executives with extensive drug development and commercialization experience.
About FORR Forrester Research Inc.
Forrester Research Inc provides independent research, data, and advisory services. It operates through the following segments: The Research segment develops and delivers research, connect, and analytics products; The consulting segment includes the revenues and the related costs of the company's consulting organization, and the Events segment is engaged in developing and hosting in-person and virtual events.